News | May 13, 2022
Increased prevalence of diabetes and product innovation to boost insulin pens market in India, says GlobalData
India has the second-largest number of adults with diabetes globally, after China
India has the second-largest number of adults with diabetes globally, after China
Candle Partners, an investment banking & advisory service for M&A among others, has closed many deals in the healthcare space. Ankit Poddar, Director, Candle Partners spoke to Thomas C Thottathil, Editor, Indianpharmapost.com about the prospects for the industry.
Revolutionary ovarian cancer rapid test available Q4 2022
With launches, continuing momentum in India, other branded markets and a pick-up in the US, Ajanta would deliver 12% revenue/PAT growth each over FY22-24
“We are committed to making India a global medical value hub by further strengthening our traditional medicine industry and boosting 'Heal in India' & 'Heal by India'
The partners also aim to expand their work to Latin America for the first time
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
The production suspension impacts commercial and clinical trial supply
Subscribe To Our Newsletter & Stay Updated
